XVIVO — Xvivo Perfusion AB Share News
0.000.00%
- SEK6.49bn
- SEK6.30bn
- SEK812.17m
Brief: Xvivo Perfusion: Breakthrough Device Designation For Heart Preservation System
Brief: Fiona Stanley Hospital Acquires XPS from XVIVO Perfusion
Brief: Xvivo Perfusion Q3 Net Income Rises To SEK 4.9 Million
Brief: Xvivo Opens Unit In Australia
Brief: Xvivo Perfusion: Issue Of Warrants Of Series 2019/2021 Fully Subscribed
New transplant research aims to salvage infected donated organs
Brief: Xvivo Perfusion Sells XPS To China
Brief: Xvivo Perfusion: Lung Bioengineering Buys XVIVO Perfusion System
Brief: Xvivo Perfusion Gets Patent Approval In Europe
Brief: XVIVO Perfusion And MyCartis Announce Collaboration
Swedish stocks: seen opening higher, SEB Q2 profit beats expectations
Brief: Xvivo Perfusion Q2 EBITDA At SEK 8.1 Million
Brief: Xvivo Gets Approval From Swedish MPA To Begin Clinical Studies With New Products
Brief: Xvivo: First XPS Sold To Canada
Brief: Xvivo's Patents For Heart Preservation Fluid Approved In US And Europe
Brief: Xvivo Gets Market Approval From FDA For Steen Solution And XPS
Brief: XVIVO Receives Market Approval For STEEN Solution And XPS
Brief: FDA Approves Device To Help Increase Access To More Lungs For Transplant
Brief: Xvivo Perfusion Q1 Adjusted EBITDA Up At SEK 8.8 Mln